11 – 20 of 82
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
RNA-seq identifies clinically relevant fusion genes in leukemia including a novel MEF2D/CSF1R fusion responsive to imatinib.
(
- Contribution to journal › Letter
-
Mark
Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS : Results from the nordic NMDSG08A phase II trial
(
- Contribution to journal › Article
-
Mark
Flavonoid and lignan intake in relation to bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
(
- Contribution to journal › Article
-
Mark
Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study
(
- Contribution to journal › Article
- 2012
-
Mark
The association of education with long-term weight change in the EPIC-PANACEA cohort
(
- Contribution to journal › Article
- 2010
-
Mark
Biokinetics Of 18F-Choline Studied In Four Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Elevated neutrophil membrane expression of proteinase 3 is dependent upon CD177 expression.
(
- Contribution to journal › Article
- 2009
-
Mark
On Running Late in Life
(
- Contribution to journal › Letter
-
Mark
Prolactin Suppresses Malonyl-CoA Concentration in Human Adipose Tissue
(
- Contribution to journal › Article
-
Mark
Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy
2009) 10th International Symposium on Myelodysplastic Syndromes In Leukemia Research 33(Suppl 1). p.49-50(
- Contribution to journal › Published meeting abstract